Drug-eluting stent
A drug-eluting stent is a small mesh tube that is placed in an artery to help keep it open and that carries a coating holding a medicine. A US government patient page on angioplasty says that doctors sometimes place a stent after a balloon has widened a blocked coronary artery, and that some stents have a medicine coating. The sources read give different purposes for the coating. The patient page says it helps prevent blood clots from forming. The US regulator's product definition for the coronary version says the drug coating is intended to inhibit restenosis. This page records no trial results, no medicine names and no advice on who should receive one.
Also called Drug-eluting stents · Coronary drug-eluting stent · DES
- Technology
- In this atlas
Overview
Technical summary
MeSH D054855 (Drug-Eluting Stents), exact. The MeSH scope note describes stents covered with materials embedded with chemicals that are gradually released into the surrounding milieu; it does not say coronary. The US regulator lists product code NIQ, Coronary Drug-Eluting Stent, as device class 3 and defines it as a metal scaffold with a drug coating, placed through a delivery catheter into a coronary artery or saphenous vein graft. The page is limited to what these three sources state: no outcome data, no antiplatelet regimen and no comparison with other stents or with balloon angioplasty alone.
How it works
A stent is a small tube of mesh that keeps an artery open from the inside. A drug-eluting stent is also covered with material from which chemicals are gradually released into the surroundings (MeSH scope note). The US regulator describes the coronary version as a metal scaffold with a drug coating, delivered on a catheter, where the coating is intended to inhibit restenosis.
Classification codes
-
NIQCoronary Drug-Eluting Stent
Strengths
- The covering gradually releases chemicals into the area around the stent (MeSH scope note).
- The US regulator states the purpose of the coating in the coronary product definition: it is intended to inhibit restenosis.
Limitations
- The sources differ on the coating's purpose: the US patient page says it helps prevent blood clots from forming, and the US regulator says it is intended to inhibit restenosis. This page does not reconcile them.
- None of the three sources reports an outcome, a complication rate or a comparison, so no benefit or harm figure is given. The patient page says angioplasty is very safe but that every invasive procedure comes with risks, and it lists possible problems of angioplasty in general, such as serious bleeding, blood clots and renewed narrowing of the artery, without rates.
- The MeSH heading does not limit the device to the coronary arteries; the US regulator product code does.
Required infrastructure
- Placement through a catheter during angioplasty. The patient page says the doctor threads a tube through the vessel to the heart using x-rays as a guide; the US regulator's definition names a delivery catheter.
Claims and evidence
No claims are published for this technology yet.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Record details
- Record id
cardio:drug-eluting-stent- Content hash
f7c40d06a29e04b2c81cdf2d5e8b98a21a6fb2e2856db59aeb6db16dfba5a209